PHAXIAM Therapeutics (Nasdaq & Euronext: FR0011471135), today announces the enrolment of the 1st patient in …
![Phage therapy for endocarditis caused by S. aureus](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7089401.jpeg?resize=760%2C427&ssl=1)
![Phage therapy for endocarditis caused by S. aureus](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7089401.jpeg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
PHAXIAM Therapeutics (Nasdaq & Euronext: FR0011471135), today announces the enrolment of the 1st patient in …
WuXi Biologics (“WuXi Bio”) (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization …
Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer …
Oncoclínicas&Co, the largest group dedicated to cancer in Latin America, and Dana-Farber Cancer Institute, a Harvard Medical …